Source link : https://newshealth.biz/health-news/pramipexole-augmentation-benefits-resistant-depression/
TOPLINE: Augmenting antidepressant treatment with pramipexole led to a significant reduction in symptoms relative to placebo in treatment-resistant major depressive disorder (MDD) at 12 weeks, a trial found. The benefits persisted over 48 weeks despite side effects, highlighting the clinical utility of pramipexole in this patient population. METHODOLOGY: This double-blind, placebo-controlled randomised trial conducted across […]
The post Pramipexole Augmentation Benefits Resistant Depression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-04 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8